Edmond de Rothschild Holding’s CureVac CVAC Stock Holding History

Edmond de Rothschild Holding’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-600	Closed	-$3.97K	–	701
2023 Q3	$3.97K	Hold	600	–	–	﹤0.01%	688
2023 Q2	$6.32K	Hold	600	–	–	﹤0.01%	698
2023 Q1	$4.18K	Hold	600	–	–	﹤0.01%	708
2022 Q4	$3.63K	Sell	600 -460	-43%	-$3.4K	﹤0.01%	766
2022 Q3	$9K	Hold	1,060	–	–	﹤0.01%	778
2022 Q2	$14K	Hold	1,060	–	–	﹤0.01%	748
2022 Q1	$21K	Hold	1,060	–	–	﹤0.01%	743
2021 Q4	$36K	Hold	1,060	–	–	﹤0.01%	730
2021 Q3	$58K	Hold	1,060	–	–	﹤0.01%	680
2021 Q2	$80K	Buy	1,060 +600	+130%	+$60K	﹤0.01%	636
2021 Q1	$42K	Buy	+460	New	+$44.6K	﹤0.01%	635

Other funds holding CVAC

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Edmond de Rothschild Holding's CVAC Position: Q4 2023 in Review

Edmond de Rothschild Holding sold out of CureVac (CVAC) in Q4 2023, closing a stake of 600 shares — an estimated $3.97K sold.

Edmond de Rothschild Holding first reported a position in CVAC in Q1 2021 and held it in 11 quarters. The position peaked at $80K in Q2 2021. 90 funds tracked by Wall St. Rank hold CVAC as of Q4 2023.

Edmond de Rothschild Holding reported no remaining CureVac position as of Q4 2023 after selling out during the quarter.
Edmond de Rothschild Holding sold 600 CureVac shares in Q4 2023, an estimated $3.97K.
Edmond de Rothschild Holding first reported a position in CureVac in Q1 2021 and held it in 11 quarters.
Edmond de Rothschild Holding's CureVac position peaked at $80K in Q2 2021.
90 funds tracked by Wall St. Rank held CureVac as of Q4 2023.

Based on Edmond de Rothschild Holding's 13F filing for Q4 2023, filed 12 Feb 2024.